Moderna Inc.’s stock erased early losses to gain more than 3% on Friday, after the biotech company posted a ...

SAN FRANCISCO-- ( BUSINESS WIRE )-- 6sense ®, the leading platform revolutionizing B2B revenue generation, today released its ...

The rush to purchase renewable energy equipment before clean energy laws get changed could juice the results of companies ...

Publishers and comics shops continue to scramble to shift to other distributors and brace themselves for lost income ...

Gilead Sciences has battled back from a pipeline disappointment last year to its highest stock price in nearly a decade.

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

The subject comes amid land battles between private residents and the Summit Carbon Solutions pipeline. Senate Bill 2322 and House Bill 1414 aim to restrict the use of eminent domain for various ...

Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...

Neurocrine Biosciences Inc. (NASDAQ:NBIX), a biopharmaceutical company focused on developing treatments for neurological and endocrine-related diseases, has been navigating a complex landscape of ...

Apple on Thursday reported its revenue was a whopping $124.3 billion in the year-end holiday quarter, but sales growth fell shy of market expectations as the iPhone faces stiff competition, ...

Foxtons Group Plc shares rose the most in almost two months after the UK estate broker said it started the new year with an under-offer sales pipeline “significantly above” the previous year ...

The market research firm said that more than 370 European venture capital-backed firms have a high probability of undertaking first-time share sales in 2025, an increase of about 24% since April ...